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RATIONALE: Vascular smooth muscle (SM) cell phenotypic modulation plays an
important role in arterial stiffening associated with aging. Serum response factor
(SRF) is a major transcription factor regulating SM genes involved in maintenance of
the contractile state of vascular SM cells. OBJECTIVE: We investigated whether SRF
and its target genes regulate intrinsic SM tone and thereby arterial stiffness.
METHODS AND RESULTS: The SRF gene was inactivated SM-specific knockout of
SRF (SRF(SMKO)) specifically in vascular SM cells by injection of tamoxifen into
adult transgenic mice. Fifteen days later, arterial pressure and carotid thickness
were lower in SRF(SMKO) than in control mice. The carotid distensibility/pressure
and elastic modulus/wall stress curves showed a greater arterial elasticity in
SRF(SMKO) without modification in collagen/elastin ratio. In SRF(SMKO),
vasodilation was decreased in aorta and carotid arteries, whereas a decrease in
contractile response was found in mesenteric arteries. By contrast, in mice with
inducible SRF overexpression, the in vitro contractile response was significantly
increased in all arteries. Without endothelium, the contraction was reduced in
SRF(SMKO) compared with control aortic rings owing to impairment of the NO
pathway. Contractile components (SM-actin and myosin light chain), regulators of the
contractile response (myosin light chain kinase, myosin phosphatase target subunit 1,
and protein kinase C-potentiated myosin phosphatase inhibitor) and integrins were
reduced in SRF(SMKO). CONCLUSIONS: SRF controls vasoconstriction in mesenteric
arteries via vascular SM cell phenotypic modulation linked to changes in contractile
protein gene expression. SRF-related decreases in vasomotor tone and cell-matrix
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